8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report

(Date of earliest event reported):

April 7, 2008

 

 

BIOPURE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE   000-15167   04-2836871

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

11 HURLEY STREET

CAMBRIDGE, MA 02141

(Address of principal executive offices and zip code)

(617) 234-6500

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(d))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 4.01. Changes in Registrant’s Certifying Accountant.

 

(b) New Independent Registered Public Accounting Firm

On April 7, 2008, Biopure Corporation appointed Vitale, Caturano & Company, Ltd. (“VCC”) as its new independent registered public accounting firm. The Audit Committee of the Board of Directors of the company made its selection after a review of audit firms that had expertise with public clients of Biopure’s size and requirements.

Prior to the engagement of VCC, neither the company nor anyone on behalf of the company consulted with VCC during the company’s two most recent fiscal years and through April 6, 2008, in any manner regarding: (A) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the company’s financial statements; or (B) any matter that was either the subject of a disagreement, as that term is defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a reportable event, as that term is defined in Item 304(a)(1)(v) of Regulation S-K.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOPURE CORPORATION
Date: April 10, 2008   By:  

/s/ Zafiris G. Zafirelis

  Name:   Zafiris G. Zafirelis
  Title:   Chairman, President and Chief Executive Officer